Yücel, MuratCarter, AdrianAllen, Amy R.Balleine, BernardClark, LukeDowling, NickiGainsbury, Sally M.Goudriaan, Anna E.Grant, Jon E.Hayes, AlanHodgins, David2019-05-012215-0366http://hdl.handle.net/1885/160806Neuroscientific explanations of gambling disorder can help people make sense of their experiences and guide the development of psychosocial interventions. However, the societal perceptions and implications of these explanations are not always clear or helpful. Two workshops in 2013 and 2014 brought together multidisciplinary researchers aiming to improve the clinical and policy-related effects of neuroscience research on gambling. The workshops revealed that neuroscience can be used to improve identification of the dangers of products used in gambling. Additionally, there was optimism associated with the diagnostic and prognostic uses of neuroscience in problem gambling and the provision of novel tools (eg, virtual reality) to assess the effectiveness of new policy interventions before their implementation. Other messages from these workshops were that neuroscientific models of decision making could provide a strong rationale for precommitment strategies and that interdisciplinary collaborations are needed to reduce the harms of gambling.MY received a Fellowship from the National Health and Medical Research Council (NHMRC) of Australia (APP1021973) and a grant from The David Winston Turner Endowment Fund outside of the submitted work. AC received a Fellowship from the Australian Research Council (ARC; DE140101097) during the study. LC received a grant from the Centre for Gambling Research at the University of British Columbia and personal fees from Cambridge Cognition Ltd and Svenska Spel outside of the submitted work. SMG reports travel grants from the Victorian Responsible Gambling Foundation (VRGF) during the study, and grants from the Star Entertainment Group, Sportsbet, and British Columbia Lotteries Corporation and personal fees from the UK Responsible Gambling Trust and Nova Scotia Provincial Lotteries and Casino Corporation outside of the submitted work. AEG reports grants from the Netherlands Organisation for Health Care Research (ZonMw) and personal fees from the German Safety Standards Authority (TÜV InterCert Saar) during the study. JG reports grants from Forest, Brainsway, Takeda, the American Foundation for Suicide Research, and the Trichotillomania Learning Center outside of the submitted work. DL reports grants from NHMRC, ARC, Gambling Research Australia (GRA), VRGF, and beyondblue; provided consultancy advice to Lundbeck; received speaking honorarium from AstraZeneca and Janssen; and received conference support from Lundbeck, outside of the submitted work. NP reports grants from the National Institutes of Health during the study and compensation from the Responsible Gambling Trust outside of the submitted work. AT reports personal fees from the VRGF and GRA, outside of the submitted work. All other authors have nothing to declare. This research was supported by funding from Monash University and the Victorian Responsible Gambling Foundation.6 pagesapplication/pdfen-AU© 2018 Elsevier Ltdgambling disorderpsychosocial interventionsneuroscience2017-0610.1016/S2215-0366(16)30369-82019-03-12